Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn's disease

R. L. West, Z. Zelinkova, G. J. Wolbink, E. J. Kuipers, P. C.F. Stokkers, C. J. Van Der Woude

Research output: Contribution to journalArticlepeer-review

211 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn's disease'. Together they form a unique fingerprint.

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases